Growth Inhibition of Formed Corneal Neovascularization Following Fosaprepitant Treatment

Acta Ophthalmologica - United States
doi 10.1111/aos.13304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Topical Bevacizumab in the Treatment of Corneal Neovascularization

Archives of Ophthalmology
2009English

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) vs Bevacizumab (Avastin)

Ocular Surface
Ophthalmology
2012English

Therapeutic Approaches for Corneal Neovascularization

Eye and Vision
2017English

Inhibition of Apoptosis for the Treatment of Corneal Endothelial Diseases

Acta Ophthalmologica
MedicineOphthalmology
2018English

Genetic Modification of Corneal Neovascularization in DSTN Corn1 Mice

Mammalian Genome
Genetics
2013English

Doxycycline-Mediated Inhibition of Choroidal Neovascularization

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2009English

Angiogenin Ameliorates Corneal Opacity and Neovascularization via Regulating Immune Response in Corneal Fibroblasts

BMC Ophthalmology
MedicineOphthalmology
2016English

Sex Differences in Corneal Neovascularization in Response to Superficial Corneal Cautery in the Rat

PLoS ONE
Multidisciplinary
2019English

Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts Following Treatment With Oncolytic Vaccinia Virus GLV-1h68

Journal of Oncology
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy